The 24-29% weight reduction seen with retatrutide at 12mg represents a 50-70% improvement over semaglutide efficacy, depending on the specific semaglutide dose and study population being compared
Based on limited human pharmacology data, ipamorelin appears relatively selective, with less pronounced effects on cortisol and prolactin secretion compared with some other GH secretagogues though this selectivity has not been extensively validated in large human trials
But the ones youve heard about lately are a lot different
Human studies are ongoing, but early evidence suggests GLP-1 drugs can help manage or prevent several age-related diseases, potentially expanding healthy lifespan
Any deviation from licensed dosing regimens should only occur under close medical supervision, as the risk-benefit profile at sub-therapeutic doses remains poorly characterised
Both routes aim to support appetite control through the same hormone pathway, but effectiveness depends on the specific product, formulation, and correct use